Stock listing
Apollomics Inc.
Selected listing: APLM · NASDAQ · USD · US
Apollomics Inc. (NASDAQ:APLM), Finance. Latest release Aug 11, 2026: Apollomics Announces $10 Million Private Placement Transaction.
- Ticker
- NASDAQ:APLM
- Asset type
- Stock
- Sector
- Finance
- Industry
- Financial Conglomerates
- Exchange
- NASDAQ
- Currency
- USD
About Apollomics Inc.
Apollomics Inc. is a public company traded under the ticker APLM in the American market. Apollomics focuses on developing innovative therapies to address unmet medical needs.
Latest news from Apollomics Inc.
Apollomics Announces $10 Million Private Placement Transaction
August 11, 2026
Apollomics Regains Full Compliance with Nasdaq Listing Requirements
July 13, 2026
Apollomics Receives Nasdaq Deficiency Notice Regarding Minimum Market Value Requirement and Updates Rights for Vebreltinib (APL-101) in Asia
June 23, 2026
Apollomics Reports Full Year 2025 Financial Results and Provides Clinical Updates and Business Progress
April 26, 2026
Apollomics Inc. Announces $2.0 Million Bridge Financing
March 31, 2026
Events
Replays
Apollomics Inc. (APLM) Q4 2023 Earnings Call
Thu, Mar 28, 2024 · 08:30 AM ET
Watch